ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000273302.1	Axitinib	Breast invasive carcinoma	0.000198171	Sensitive
ENSG00000273302.1	Axitinib	Cervical squamouscell carcinoma and endocervical adenocarcinoma	0.01126162	Sensitive